Kang, M., Chen, G., Liu, X., Jin, X., Wu, D., Guo, Q., Wu, H., Chen, J. (2026). A multi-center phase II study of chemotherapy (SOX) plus tislelizumab as first-line therapy for gastric cancer with liver metastasis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16047